Mei Ri Jing Ji Xin Wen·2025-10-31 12:25Core Viewpoint - Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., a shareholder holding 9.23% of Shanhe Pharmaceutical Auxiliary (300452.SZ), plans to reduce its stake by up to 6.9787 million shares, representing 3.00% of the company's total share capital, due to its own funding needs [1] Summary by Sections Shareholder Reduction Plan - The reduction will occur through centralized bidding and block trading methods within 90 days starting from 15 trading days after the announcement, specifically from November 24, 2025, to February 21, 2026 [1] - In any consecutive 90-day period, the block trading reduction will not exceed 2% of the company's total share capital (4.6525 million shares), while the centralized bidding reduction will not exceed 1% (2.3262 million shares) [1]